APA (7th ed.) Citation

I, I., A, T., D, G., L, S., R, M., A, V., . . . L, L. (2025). Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience. Hematological oncology, 43(1), e70033. https://doi.org/10.1002/hon.70033

Chicago Style (17th ed.) Citation

I, Innocenti, et al. "Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience." Hematological Oncology 43, no. 1 (2025): e70033. https://doi.org/10.1002/hon.70033.

MLA (9th ed.) Citation

I, Innocenti, et al. "Acalabrutinib in High-Risk Chronic Lymphocytic Leukaemia Naïve Patients: An Italian Multicenter Retrospective Observational Real-Life Experience." Hematological Oncology, vol. 43, no. 1, 2025, p. e70033, https://doi.org/10.1002/hon.70033.